Effect of preexisting immunity to adenovirus on transgene product-specific genital T cell responses on vaccination of mice with a homologous vector

Journal of Infectious Diseases

Volumn 203, Issue 8, 2011, Pages 1073-1081

  Haut, Larissa Herkenhoff ^a,c   Ratcliffe, Sarah ^b   Pinto, Aguinaldo Roberto ^c   Ertl, Hildegund ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CHEMOKINE RECEPTOR CCR5; GAG PROTEIN; GRANZYME B; HERMES ANTIGEN; NEUTRALIZING ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FEMALE GENITAL SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

ADENOVIRIDAE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; MICE; MICE, INBRED BALB C; VACCINATION; VAGINA; VIRAL VACCINES;

EID: 79953320406     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq161     Document Type: Article

References (24)

1. Buchbinder SP, Mehrotra DV, Duerr A, et al. Step Study Protocol Team. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebocontrolled, test-of-concept trial. Lancet 2008; 372:1881-93.
2. McElrath MJ, De Rosa SC, Moodie Z, et al. Step Study Protocol Team. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 2008; 372:1894-905.
3. Xiang Z, Li Y, Cun A, et al. Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa. Emerg Infect Dis 2006; 12:1596-9. (Pubitemid 44570909)
4. Chen H, Xiang ZQ, Li Y, et al. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae. J Virol 2010; 84:10522-32.
5. Fitzgerald JC, Gao GP, Reyes-Sandoval A, et al. A simian replicationdefective adenoviral recombinant vaccine to HIV-1 gag. J Immunol 2003; 170:1416-22. (Pubitemid 36139509)
6. McCoy K, Tatsis N, Korioth-Schmitz B, et al. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors. J Virol 2007; 81:6594-604. (Pubitemid 46878063)
7. Inungu J, MaloneBeach E, Betts J. Male circumcision and the risk of HIV infection. AIDS Read 2005; 15:130-1.
8. de Jong MA, de Witte L, Taylor ME, Geijtenbeek TB. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function. J Immunol 2010; 185:1633-41.
9. Hutnick NA, Carnathan DG, Dubey SA, et al. Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells. Nat Med 2009; 15:876-8.
10. Tatsis N, Ertl HC. Adenoviruses as vaccine vectors. Mol Ther 2004; 10:616-29. (Pubitemid 39272851)
11. Tatsis N, Fitzgerald JC, Reyes-Sandoval A, et al. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood 2007; 110:1916-23. (Pubitemid 47443905)
12. de Souza AP, Haut LH, Silva R, et al. Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus. Vaccine 2007; 25:109-16. (Pubitemid 44855239)
13. DiMenna L, Latimer B, Parzych E, et al. Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathway. J Immunol 2010; 184:5475-84.
14. Sauce D, Almeida JR, Larsen M, et al. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS 2007; 21:2005-13. (Pubitemid 47462149)
15. Muruve DA. The innate immune response to adenovirus vectors. Hum Gene Ther 2004; 15:1157-66. (Pubitemid 40052429)
16. Bengsch B, Seigel B, Ruhl M, et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 2010; 6:e1000947.
17. Perreau M, Pantaleo G, Kremer EJ. Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells. J Exp Med 2008; 205:2717-25.
18. Varnavski AN, Calcedo R, Bove M, Gao G, Wilson JM. Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice. Gene Ther 2005; 12:427-36. (Pubitemid 40394295)
19. + T cells in lymphoid tissues during simian immunodeficiency virus infection. J Virol 2000; 74:11001-7.
20. Ebert LM, McColl SR. Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes. J Immunol 2002; 168:65-72. (Pubitemid 34014103)
21. Rosette C, Werlen G, Daniels MA, et al. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 2001; 15:59-70. (Pubitemid 32728320)
22. Valitutti S, Müller S, Dessing M, Lanzavecchia A. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med 1996; 183:1917-21. (Pubitemid 26134333)
23. Boyman O, Létourneau S, Krieg C, Sprent J. Homeostatic proliferation and survival of naïve and memory T cells. Eur J Immunol 2009; 39:2088-94.
24. Romero P, Zippelius A, Kurth I, et al. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 2007; 178:4112-9. (Pubitemid 46492360)